Applied DNA Sciences, Inc. (APDN)
NASDAQ: APDN · Real-Time Price · USD
0.157
-0.005 (-2.91%)
At close: Feb 21, 2025, 4:00 PM
0.159
+0.002 (1.53%)
After-hours: Feb 21, 2025, 7:54 PM EST
Applied DNA Sciences Cash Flow Statement
Financials in millions USD. Fiscal year is October - September.
Millions USD. Fiscal year is Oct - Sep.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | Sep '20 Sep 30, 2020 |
| Net Income | -8.53 | -6.99 | -9.95 | -8.27 | -14.29 | -13.03 | |
| Depreciation & Amortization | 0.46 | 0.7 | 1.36 | 1.29 | 0.84 | 0.29 | |
| Other Amortization | - | - | - | - | - | 0.03 | |
| Loss (Gain) From Sale of Assets | - | - | -0.01 | - | 0.21 | - | |
| Asset Writedown & Restructuring Costs | 0.01 | - | 0.06 | - | 0.82 | - | |
| Stock-Based Compensation | 0.26 | 0.57 | 1.03 | 2.52 | 1.67 | 1 | |
| Provision & Write-off of Bad Debts | 0.01 | - | -0.24 | 0.27 | 0.03 | 0.05 | |
| Other Operating Activities | -4.46 | -6.85 | -0.93 | -5.74 | 0.94 | -0 | |
| Change in Accounts Receivable | -0.47 | -0.11 | 3.05 | -0.53 | -2.64 | 0.6 | |
| Change in Inventory | -0.09 | -0.11 | 0.27 | 0.77 | -0.87 | -0.35 | |
| Change in Accounts Payable | -0.4 | -0.48 | -1.35 | 0.93 | 0.09 | 0.43 | |
| Change in Unearned Revenue | 0.13 | -0.02 | -0.29 | 0.28 | -0.23 | -0.12 | |
| Change in Other Net Operating Assets | -0.2 | -0.43 | 0.77 | -0.49 | 0.03 | -0.03 | |
| Operating Cash Flow | -13.28 | -13.71 | -6.22 | -8.98 | -13.39 | -11.14 | |
| Capital Expenditures | -0.52 | -0.41 | -1.14 | -0.49 | -2.55 | -1.06 | |
| Sale of Property, Plant & Equipment | - | - | 0.05 | - | - | - | |
| Investing Cash Flow | -0.52 | -0.41 | -1.1 | -0.49 | -2.55 | -1.06 | |
| Long-Term Debt Issued | - | - | - | - | - | 0.85 | |
| Total Debt Issued | - | - | - | - | - | 0.85 | |
| Long-Term Debt Repaid | - | - | - | - | -1.67 | -0.11 | |
| Net Debt Issued (Repaid) | - | - | - | - | -1.67 | 0.74 | |
| Issuance of Common Stock | 19.66 | 13.4 | - | 18.13 | 16.37 | 18.7 | |
| Other Financing Activities | 0.08 | - | - | - | - | - | |
| Financing Cash Flow | 19.74 | 13.4 | - | 18.13 | 14.7 | 19.43 | |
| Net Cash Flow | 5.94 | -0.72 | -7.31 | 8.66 | -1.23 | 7.23 | |
| Free Cash Flow | -13.8 | -14.12 | -7.36 | -9.47 | -15.94 | -12.21 | |
| Free Cash Flow Margin | -369.42% | -411.47% | -55.05% | -52.10% | -176.53% | -631.98% | |
| Free Cash Flow Per Share | -1.18 | -3.56 | -11.26 | -21.11 | -46.08 | -62.29 | |
| Cash Interest Paid | - | - | - | - | - | 0.05 | |
| Levered Free Cash Flow | -9.06 | -9.04 | -3.68 | -4.48 | -10.48 | -7.17 | |
| Unlevered Free Cash Flow | -9.06 | -9.04 | -3.68 | -4.48 | -10.48 | -7.12 | |
| Change in Net Working Capital | 1 | 1.14 | -1.91 | -0.93 | 2.62 | -0.49 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.